Business Development and Licensing Expert Vaibhav Saini joins CRI as Senior Commercialization Manager

Feb 17, 2023 | CRI

Northeastern’s innovation ecosystem is growing every day, with exciting advancements such as the launch of the National Academy of Inventors (NAI) Northeastern Chapter and an ever-expanding portfolio of innovations, spin-off companies, industry partnerships, issued patents, and patent applications. As part of these innovation and expansion efforts, Northeastern’s Center for Research Innovation (CRI) is proud to announce that Vaibhav Saini has joined the CRI as Senior Commercialization Manager.

Vaibhav SainiVaibhav Saini, Ph.D., enjoys technology transfer and business development activities to support early-stage research commercialization, including new research tools, small molecules, biologics, data/AI in healthcare, diagnostics, and therapeutics. Prior to joining CRI, Vaibhav served as Senior Business Development and Licensing Manager at Dartmouth College, where he performed marketing and licensing activities for early-stage technologies and startups in life sciences. Previously, he performed business and technology development at MilliporeSigma, Merck KGaA, a 352-year-old global science and technology company. Previously, as Licensing Director for Life Sciences at the University of Connecticut, he encouraged academic-industry interactions and increased licensing and startup formation activities for technologies in chemistry, biomedical engineering, medical devices, drug development, animal health, and agriculture. Before that, as an Instructor in Medicine at Harvard Medical School, he researched hormonal regulation of osteoporosis, alopecia, and hepatic steatosis.

“Research is growing rapidly at Northeastern, which requires expert commercialization support to help fully realize the promise of these exciting discoveries,” says Vaibhav. “CRI protects intellectual property and provides resources to help turn research into products that benefit society. I look forward to contributing to scaling and accelerating NU’s technology transfer efforts along with my colleagues at CRI.”

In his new role as Senior Commercialization Manager at CRI, Vaibhav will support the commercialization of life sciences research at NU by helping with intellectual property protection, industry collaboration, and licensing.

“Continued investment in basic research seeds applied innovation. Therefore, it is important to value research to gain new knowledge and appreciate that some research output will result in useful products.”

Learn more

If you are interested in learning more about how the CRI can help you accelerate your research into industry and bridge the gap between laboratory research and need-based solutions, email our team at [email protected] or submit a contact form.

Written by Elizabeth Creason